Table 1.
Clinical and histopathological information of samples compared by linear regression.
| Categories | Clinical Information | Histopathological Information (Average) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | Age of Diagnosis | Gender | Disease Stage | Treatment | Connective Tissue Content | Lymphatic Score | Tumor Cells Content | Adjacent Lymph Node Area | Pigmentation Score | Predominant Cytoplasm | Lymphatic Distribution | Necrosis Content | Lymphocyte Density |
| MM16 | 55 | Female | 4 | Nontreated | 9.8 | 3 | 53.5 | 1.8 | 3 | 1 | 2 | 35 | 1 |
| MM23 | 71 | Female | 4 | Nontreated | 19 | 3.7 | 50.3 | 30.7 | 1 | 2 | 1.7 | 0 | 2 |
| MM59 | 38 | Female | 4 | Nontreated | 12.5 | 2 | 62 | 0 | 2 | 2 | 1 | 25.5 | 1 |
| MM65 | 59 | Female | 4 | Nontreated | 11.7 | 2 | 67.3 | 0 | 1 | 2 | 1 | 21 | 1 |
| MM84 | 52 | Female | 4 | Nontreated | 1.3 | 2 | 71.3 | 0 | 1.3 | 1 | 1 | 27.3 | 1 |
| MM93 | 70 | Male | 4 | Nontreated | 83 | 3 | 15 | 2 | 1 | 0 | 1 | 0 | 2 |
| MM87 | 29 | Female | 3 | BRAF | 7 | 3 | 62 | 30 | 0 | 1 | 1 | 1 | 2 |
| MM100 | 64 | Female | 3 | BRAF | 8 | 2 | 80 | 5 | 0 | 1 | 1 | 7 | 1 |
| MM103 | 61 | Male | 3 | BRAF | 2 | 2 | 98 | 0 | 0 | 2 | 1 | 0 | 1 |
| MM60 | 77 | Female | 3 | Chemotherapy | 2 | 0.7 | 98 | 0 | 0.7 | 2 | 0.3 | 0 | 0.3 |
| MM71 | 61 | Male | 4 | Chemotherapy | 7.7 | 3 | 92.3 | 0 | 3 | 2 | 1 | 0 | 2 |
| MM82 | 76 | Female | 3 | Chemotherapy | 13.3 | 2 | 65 | 16.7 | 0 | 1 | 1 | 5 | 1 |
| MM98 | 55 | Male | 4 | Chemotherapy | 17 | 4 | 75 | 0 | 2 | 0 | 2 | 8 | 2 |
| MM22 | 44 | Male | 3 | Interferon | 5 | 5 | 25.7 | 69 | 3 | 2 | 3 | 0.3 | 2 |
| MM52 | 68 | Female | 3 | Interferon | 7 | 2 | 93 | 0 | 1 | 1 | 1 | 0 | 1 |
| MM54 | 81 | Female | 4 | Interferon + Chemotherapy | 6.3 | 1.3 | 57.7 | 0 | 0 | 2 | 0.7 | 36 | 0.7 |